Enhabit, Inc. (NYSE:EHAB) Short Interest Up 6.6% in December

Enhabit, Inc. (NYSE:EHAB) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 1,290,000 shares, a growth of 6.6% from the November 30th total of 1,210,000 shares. Approximately 2.9% of the shares of the company are sold short. Based on an average daily trading volume, of 412,800 shares, the days-to-cover ratio is presently 3.1 days.

Insider Buying and Selling

In related news, Director Jeffrey Bolton purchased 4,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The shares were purchased at an average price of $8.69 per share, with a total value of $34,760.00. Following the completion of the acquisition, the director now directly owns 98,144 shares in the company, valued at $852,871.36. This represents a 4.25 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Stuart M. Mcguigan acquired 15,000 shares of Enhabit stock in a transaction on Tuesday, December 10th. The shares were bought at an average cost of $8.81 per share, with a total value of $132,150.00. Following the completion of the purchase, the director now owns 46,810 shares in the company, valued at $412,396.10. The trade was a 47.15 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Enhabit

A number of large investors have recently bought and sold shares of the stock. FMR LLC grew its holdings in shares of Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after buying an additional 1,967 shares in the last quarter. Quarry LP grew its stake in Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after acquiring an additional 2,621 shares during the period. Gladius Capital Management LP raised its holdings in Enhabit by 78.2% in the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock valued at $49,000 after acquiring an additional 2,747 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of Enhabit by 19.6% during the 3rd quarter. Franklin Resources Inc. now owns 32,382 shares of the company’s stock worth $256,000 after purchasing an additional 5,317 shares during the period. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Enhabit by 1.5% during the second quarter. Bank of New York Mellon Corp now owns 400,575 shares of the company’s stock worth $3,573,000 after purchasing an additional 5,936 shares during the last quarter.

Enhabit Stock Performance

Shares of EHAB stock opened at $7.81 on Thursday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The stock has a market cap of $392.72 million, a PE ratio of -3.37 and a beta of 1.89. Enhabit has a 1 year low of $6.85 and a 1 year high of $11.74. The stock has a fifty day moving average price of $7.72 and a 200 day moving average price of $8.18.

Enhabit (NYSE:EHAB) last posted its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. During the same quarter last year, the business posted $0.03 earnings per share. Sell-side analysts forecast that Enhabit will post 0.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and lifted their price objective for the company from $8.25 to $9.50 in a report on Monday, December 9th. Leerink Partners restated a “market perform” rating and issued a $8.00 price target (down from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Enhabit has a consensus rating of “Hold” and a consensus target price of $8.75.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.